Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 16, Issue 1, Pages 27-39
Publisher
Informa UK Limited
Online
2016-10-13
DOI
10.1080/14740338.2017.1247807
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles
- (2016) A. J. Krentz et al. DIABETES OBESITY & METABOLISM
- SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
- (2016) Naveed Sattar et al. DIABETOLOGIA
- Evaluation of the Cardiovascular Risk of Naltrexone-Bupropion
- (2016) Joshua M. Sharfstein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events
- (2016) Rohan Khera et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Management of obesity
- (2016) George A Bray et al. LANCET
- Topiramate use during pregnancy and major congenital malformations in multiple populations
- (2015) Patricia Tennis et al. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
- Biologic Responses to Weight Loss and Weight Regain: Report From an American Diabetes Association Research Symposium
- (2015) Rudolph L. Leibel et al. DIABETES
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- (2015) Caroline M. Apovian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Emergency Department Visits for Adverse Events Related to Dietary Supplements
- (2015) Andrew I. Geller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and tolerability of medications approved for chronic weight management
- (2015) Ken Fujioka Obesity
- Clinical trial success rates of anti-obesity agents: the importance of combination therapies
- (2015) H. T. Hussain et al. Obesity Reviews
- Topiramate use during pregnancy and major congenital malformations in multiple populations
- (2015) Patricia Tennis et al. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
- Risk of Angle-Closure Glaucoma With Bupropion and Topiramate
- (2015) Richard J. Symes et al. JAMA Ophthalmology
- Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large U.S. Managed Care Network
- (2015) Joshua D. Stein et al. PLoS One
- Bupropion abuse and overdose
- (2014) N. Stall et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- An 11-year review of bupropion insufflation exposures in adults reported to the California Poison Control System
- (2014) J. C. Lewis et al. CLINICAL TOXICOLOGY
- Weight-Loss Therapy in Type 2 Diabetes: Effects of Phentermine and Topiramate Extended Release
- (2014) W. Timothy Garvey et al. DIABETES CARE
- Why are anti-obesity drugs stigmatized?
- (2014) Bruno Halpern et al. Expert Opinion On Drug Safety
- The Risk and Management of Kidney Stones From the Use of Topiramate and Zonisamide in Migraine and Idiopathic Intracranial Hypertension
- (2014) Yasmin Idu Jion et al. HEADACHE
- Cardiovascular effects of phentermine and topiramate
- (2014) Jens Jordan et al. JOURNAL OF HYPERTENSION
- Effectiveness of Primary Care–Relevant Treatments for Obesity in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force
- (2013) Erin S. LeBlanc et al. ANNALS OF INTERNAL MEDICINE
- Metabolic disturbances and renal stone promotion on treatment with topiramate: a systematic review
- (2013) Valentina G. Dell'Orto et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
- (2013) P. Hollander et al. DIABETES CARE
- Withdrawal syndrome caused by naltrexone in opioid abusers
- (2013) H Hassanian-Moghaddam et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Addiction potential of phentermine prescribed during long-term treatment of obesity
- (2013) E J Hendricks et al. INTERNATIONAL JOURNAL OF OBESITY
- The Merits of Subtyping Obesity
- (2013) Alison E. Field et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
- (2013) Paul A. James et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype–targeted drugs
- (2013) Herbert Y. Meltzer et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti-hypertensive treatment preserves appetite suppression while preventing cardiovascular adverse effects of tesofensine in rats
- (2013) Bo Hjorth Bentzen et al. Obesity
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- Use of Prescription Antiobesity Drugs in the United States
- (2013) Christian Hampp et al. PHARMACOTHERAPY
- Acute Bilateral Angle Closure
- (2013) Yao Liu et al. JAMA Ophthalmology
- Fixed-dose combination of phentermine–topiramate for the treatment of obesity
- (2013) Bruno Halpern et al. Expert Review of Clinical Pharmacology
- Management of Obesity in the National Health and Nutrition Examination Survey (NHANES), 2007–2008
- (2012) Nithushi R. Samaranayake et al. ANNALS OF EPIDEMIOLOGY
- Food and Drug Administration's Obesity Drug Guidance Document
- (2012) Eric Colman CIRCULATION
- The defence of body weight: a physiological basis for weight regain after weight loss
- (2012) Priya Sumithran et al. CLINICAL SCIENCE
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- Topiramate Treatment Improves Hypothalamic Insulin and Leptin Signaling and Action and Reduces Obesity in Mice
- (2012) Andrea M. Caricilli et al. ENDOCRINOLOGY
- Antiepileptic drugs and suicidality
- (2012) Konstantinos N Fountoulakis et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The FDA's Assessment of Two Drugs for Chronic Weight Management
- (2012) Eric Colman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
- (2011) W Timothy Garvey et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Bupropion for Smoking Cessation in Patients With Acute Coronary Syndrome
- (2011) David Planer et al. ARCHIVES OF INTERNAL MEDICINE
- Teratogenicity of the newer antiepileptic drugs – the Australian experience
- (2011) F.J.E. Vajda et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Combination treatment to CONQUER obesity?
- (2011) Krupa Shah et al. LANCET
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Blood Pressure and Heart Rate Effects, Weight Loss and Maintenance During Long-Term Phentermine Pharmacotherapy for Obesity
- (2011) Ed J. Hendricks et al. Obesity
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials
- (2011) C. K. Kramer et al. Obesity Reviews
- A Study of Abrupt Phentermine Cessation in Patients in a Weight Management Program
- (2010) Ed J Hendricks et al. AMERICAN JOURNAL OF THERAPEUTICS
- Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity
- (2010) J. G. Kang et al. DIABETES OBESITY & METABOLISM
- Twenty Percent of a Representative Sample of Patients Taking Bupropion Have Abnormal, Asymptomatic Electroencephalographic Findings
- (2010) Matthew Macaluso et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
- (2010) Thomas A. Wadden et al. Obesity
- Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives
- (2010) Doodipala Samba Reddy Expert Review of Clinical Pharmacology
- Phentermine cardiovascular safety
- (2009) Richard B. Rothman et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Naltrexone for the treatment of obesity: review and update
- (2009) Michael William Lee et al. EXPERT OPINION ON PHARMACOTHERAPY
- Tesofensine and weight loss
- (2009) Adam Gilden Tsai LANCET
- How Physician Obesity Specialists Use Drugs to Treat Obesity
- (2009) Ed J. Hendricks et al. Obesity
- Comorbidities of Obesity
- (2009) Kavitha Bhat Schelbert PRIMARY CARE
- Molecular Pharmacodynamics, Clinical Therapeutics, and Pharmacokinetics of Topiramate
- (2008) Richard P. Shank et al. CNS Neuroscience & Therapeutics
- Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial
- (2008) Arne Astrup et al. LANCET
- Naltrexone for the Management of Alcohol Dependence
- (2008) Raymond F. Anton NEW ENGLAND JOURNAL OF MEDICINE
- Rational Design of a Combination Medication for the Treatment of Obesity
- (2008) Frank L. Greenway et al. Obesity
- Pharmacokinetic interactions between contraceptives and antiepileptic drugs
- (2008) Anne Sabers SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started